Magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) have been gaining acceptance as tools in the evaluation of prostate cancer. We compared the accuracy of transrectal ultrasound (TRUS)-guided biopsy and dynamic contrast-enhanced MRI combined with three-dimensional (3D) MRSI in locating prostate tumours and determined the influence of prostate weight on MRI accuracy.Comparative StudyJournal ArticleSCOPUS: re.jinfo:eu-repo/semantics/publishe
Item does not contain fulltextBACKGROUND: The current diagnosis of prostate cancer (PCa) uses transr...
Prostate cancer is the second most common cause of cancer related death in the United States and the...
Copyright © 2013 Kevin Krughoff et al.This is an open access article distributed under the Creative ...
Purpose: To establish the additional value of 3D magnetic resonance spectroscopy (3D-MRS) imaging to...
Magnetic resonance imaging may improve the staging of prostate cancer compared with clinical evaluat...
PURPOSE: To prospectively determine the accuracies of T2-weighted magnetic resonance (MR) imaging, d...
Aims: The main objective of our study was to evaluate the efficacy of End. MRI and MRSI in (1) detec...
Magnetic resonance imaging is attracting increasing attention from the uroradiological community as ...
Prostate cancer is the second most common cancer in men, with 1.1 million new cases worldwide report...
ObjectiveThe objective of this study was to compare the accuracy of T2-weighted magnetic resonance (...
BACKGROUND: Knowledge of significant prostate (sPCa) locations being missed with magnetic resonance ...
PURPOSE: The purpose of this study was to compare the diagnostic performance of 3 Tesla, 3-dimension...
Prostate cancer (PCa) is the third most common cancer in the world and becomes more prevalent with a...
To establish the additional value of MR Spectroscopy (3D CSI MRS Three-dimensional Chemical Shift Im...
Multi-parametric magnetic resonance imaging (mpMRI) has been increasingly used to diagnose clinicall...
Item does not contain fulltextBACKGROUND: The current diagnosis of prostate cancer (PCa) uses transr...
Prostate cancer is the second most common cause of cancer related death in the United States and the...
Copyright © 2013 Kevin Krughoff et al.This is an open access article distributed under the Creative ...
Purpose: To establish the additional value of 3D magnetic resonance spectroscopy (3D-MRS) imaging to...
Magnetic resonance imaging may improve the staging of prostate cancer compared with clinical evaluat...
PURPOSE: To prospectively determine the accuracies of T2-weighted magnetic resonance (MR) imaging, d...
Aims: The main objective of our study was to evaluate the efficacy of End. MRI and MRSI in (1) detec...
Magnetic resonance imaging is attracting increasing attention from the uroradiological community as ...
Prostate cancer is the second most common cancer in men, with 1.1 million new cases worldwide report...
ObjectiveThe objective of this study was to compare the accuracy of T2-weighted magnetic resonance (...
BACKGROUND: Knowledge of significant prostate (sPCa) locations being missed with magnetic resonance ...
PURPOSE: The purpose of this study was to compare the diagnostic performance of 3 Tesla, 3-dimension...
Prostate cancer (PCa) is the third most common cancer in the world and becomes more prevalent with a...
To establish the additional value of MR Spectroscopy (3D CSI MRS Three-dimensional Chemical Shift Im...
Multi-parametric magnetic resonance imaging (mpMRI) has been increasingly used to diagnose clinicall...
Item does not contain fulltextBACKGROUND: The current diagnosis of prostate cancer (PCa) uses transr...
Prostate cancer is the second most common cause of cancer related death in the United States and the...
Copyright © 2013 Kevin Krughoff et al.This is an open access article distributed under the Creative ...